BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MITF, WS2A, ENSG00000187098, 4286 AND Treatment
8 results:

  • 1. mitf Downregulation Induces Death in Human Mast Cell leukemia Cells and Impairs IgE-Dependent Degranulation.
    Proaño-Pérez E; Ollé L; Guo Y; Aparicio C; Guerrero M; Muñoz-Cano R; Martin M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834926
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
    da Cunha-Bang C; Rostgaard K; Andersen MA; Rotbain EC; Grønbaek K; Frederiksen H; Niemann CU; Hjalgrim H
    Br J Haematol; 2021 Apr; 193(2):339-345. PubMed ID: 33570184
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of mitf and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study.
    Beberok A; Rok J; Rzepka Z; Marciniec K; Boryczka S; Wrześniok D
    Toxicol In Vitro; 2020 Aug; 66():104884. PubMed ID: 32437906
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dasatinib, a second-generation tyrosine kinase inhibitor, induces melanogenesis via ERK-CREB-mitf-tyrosinase signaling in normal human melanocytes.
    Kang B; Kim Y; Park TJ; Kang HY
    Biochem Biophys Res Commun; 2020 Mar; 523(4):1034-1039. PubMed ID: 31973810
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The transcription factor mitf is a critical regulator of GPNMB expression in dendritic cells.
    Gutknecht M; Geiger J; Joas S; Dörfel D; Salih HR; Müller MR; Grünebach F; Rittig SM
    Cell Commun Signal; 2015 Mar; 13():19. PubMed ID: 25889792
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inhibitory effects of imatinib mesylate on human epidermal melanocytes.
    Wang Y; Zhao Y; Liu L; Zhang L; Xiao H; Wu K; Xu Y; Hu Y; Fu H; Cao W; Luo Y; Huang H
    Clin Exp Dermatol; 2014 Mar; 39(2):202-8. PubMed ID: 24479586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hypopigmented macules secondary to imatinib for the treatment of chronic myeloid leukemia: a histopathologic and immunohistochemical study.
    Llamas-Velasco M; Fraga J; Kutzner H; Steegmann JL; García-Diez A; Requena L
    J Cutan Pathol; 2014 May; 41(5):417-26. PubMed ID: 24467724
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
    Valent P; Ghannadan M; Akin C; Krauth MT; Selzer E; Mayerhofer M; Sperr WR; Arock M; Samorapoompichit P; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2004 Aug; 34 Suppl 2():41-52. PubMed ID: 15291805
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.